Abstract:Purpose: Uterine cancer, including early onset cases, is increasing among all women, particularly in minority populations. Despite nearly 25% of cancers occurring in younger women, changes in tumor characteristics (e.g., histology) by race/ethnicity remain poorly understood. We examined incidence rates and 5-year relative survival of uterine cancer among women aged 20-49, overall and by race/ethnicity and histology. Methods: We used the Surveillance, Epidemiology, and End Results Program (SEER 22) Research Plus Data, representing 47.9% of the total U.S. population. We included women aged 20-49 years with microscopically confirmed malignant uterine cancer (diagnosed 2000-2019) to calculate age-adjusted incidence and age-standardized 5-year relative survival (2000-2018) overall and by race/ethnicity and histology. Time trends were described across two time periods: 2000-2009 and 2010-2019. All analyses were conducted using SEER*Stat; incidence rates were presented for per 100,000 population. Results: We included 57,128 cases (55% Non-Hispanic [NH]-White, 9% NH-Black, 10% NH-Asian/Pacific Islander [PI], and 25% Hispanic). From the period of 2000-2009 to 2010-2019, the proportion of cases that were 20-29 and 30-39 increased by 1% and 4%, respectively. Overall, incidence increased over time for all women (8.7 in 2000-2009 to. 10.4 in 2010-2019), and increases were observed for both endometrioid and non-endometrioid subtypes. In the most recent period, rates were highest for endometrioid subtypes (8.4), followed by sarcomas (1.0), and non-endometrioid subtypes (0.7). Rates for endometrioid and non-endometrioid cancers were highest in Hispanics (9.9 and 0.8) and NH-Asian/Pacific Islanders (9.7 and 0.8), respectively and lowest in NH-Blacks (5.5 and 0.6). Rates of sarcomas were highest in NH-Blacks (1.5). 5-year relative survival remained relatively unchanged over time in most racial/ethnic groups, except NH-Blacks experienced slight improvement (57% to 60%). In terms of histology, survival increased for endometrioid (87% to 89%) and non-endometrioid cases (54% to 58%) and decreased for sarcomas (46% to 42%). Conclusions: Early onset uterine cancer is rising in all women, and for both endometrioid and non-endometrioid subtypes. Of interest is the differences in the rates by histology when compared the full U.S. population: Among women aged <50 years, rates of uterine sarcomas were higher compared to non-endometrioid subtypes. These findings are concerning given that sarcomas are associated with poor prognosis and were the only cases to show decreased 5-year survival in our analysis. While rates of non-endometrioid subtypes are known to be higher among NH-Black women in the U.S., we did not observe a striking racial difference among early onset cases. In fact, NH-Black women had the lowest rates of endometrioid and non-endometrioid subtypes, but highest rates of sarcomas compared to others. Next step for this analysis is hysterectomy correction, which, while expected to be relatively lower among women aged<50 years, is known to vary by race/ethnicity. Citation Format: Akemi T. Wijayabahu, Megan A. Clarke. Early onset uterine corpus cancer incidence rates and 5-year relative survival by histologic subtype and race/ethnicity among women aged 20-49 years [abstract]. In: Proceedings of the AACR Special Conference on Endometrial Cancer: Transforming Care through Science; 2023 Nov 16-18; Boston, Massachusetts. Philadelphia (PA): AACR; Clin Cancer Res 2024;30(5_Suppl) nr B021.

Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancers

Nationwide Surveillance in Uterine Cancer: Survival Analysis and the Importance of Birth Cohort: 30-Year Population-Based Registry in Taiwan

Trends in uterine cancer incidence in the United States: The contribution of age, period and cohort effects

A Clinicopathologic and Prognostic Analysis of 115 Cases of Endometrial Carcinoma

Uterine cancer incidence trends and 5-year relative survival by race/ethnicity and histology among women under 50 years

Abstract B021: Early onset uterine corpus cancer incidence rates and 5-year relative survival by histologic subtype and race/ethnicity among women aged 20-49 years

Trends and sex‐specific incidence of upper urinary tract cancer in Taiwan: A birth cohort study

Trends in the incidence and mortality of cervical, ovarian, and corpus uteri cancers in Wales, UK: A joinpoint regression analysis from 2002 to 2021

Trends in endometrial carcinoma: experience of a single institute for four decades

Trends of uterine carcinosarcoma in the United States

Influence of Uterine Corpus Invasion on Prognosis in Stage IA2-IIB Cervical Cancer: A Multicenter Retrospective Cohort Study.

Secular Increasing Trends in Female Thyroid Cancer Incidence in Taiwan

Temporal Trends in Treatment and Outcomes of Endometrial Carcinoma in the United States, 2005–2020

Time trend of global uterine cancer burden: an age-period-cohort analysis from 1990 to 2019 and predictions in a 25-year period

Clinical and pathological analysis of 1299 patients with endometrial carcinoma

Age Specific Risks of Uterine Cancer in Type 2 Diabetes and Associated Comorbidities in Taiwan

Comparative analyses of clinical and pathological characteristics between types 1 and 2 endometrial uterine cancers

The Clinicopathological Features and Prognoses of Lower Uterine Segment Cancer: A Retrospective, Single-Center Cohort Study

Trends in Incidence Rates, Mortality Rates, and Age-Period-Cohort Effects of Cervical Cancer — China, 2003–2017

Trends in Endometrial Cancer Incidence in the United States by Race/Ethnicity and Age of Onset from 2000 to 2019

Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer